NOUVEAUX COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET/OU DE L'ANGIOPATHIE AMYLOÏDE CÉRÉBRALE
- 专利权人:
- Amicus Therapeutics; Inc.
- 发明人:
- 申请号：
- EP16820502.9
- 公开号：
- EP3390408A1
- 申请日:
- 2016.12.14
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- Described herein are novel compounds and methods for the treatment and/or prevention of cerebral amyloidoses such as Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA).L'invention concerne de nouveaux composés et des procédés pour le traitement et/ou la prévention d'amyloïdoses cérébrales telles que la maladie d'Alzheimer (MA) et/ou l'angiopathie amyloïde cérébrale (AAC).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NOUVEAUX COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET/OU DE L'ANGIOPATHIE AMYLOÏDE CÉRÉBRALE
- BIOMARKERS AND TREATMENTS FOR CEREBRAL AMYLOID ANGIOPATHY (CAA)
- compound, radiopharmaceutical formulation, pharmaceutical composition, use of the compound, mixing, methods of collecting data for the diagnosis of an amyloid-associated disease or condition, determining the extent of amyloidogenic plaque burden in a tissue and / or body fluid, collecting data to determine a predisposition to an amyloid-associated disease or condition in a patient, to collect data to monitor a minimal residual disease in a patient following treatment with an antibody or vaccine composition, to collect data to predict a patient's ability to react. a patient being treated with a
